Clinical trial · Observational
In Vivo Confocal Imaging of Oral Mucosa
A Pilot Study: In Vivo Reflectance Confocal Imaging for Detection of Neoplasia of Oral Mucosa
NCT00502125CI-TRIAL-00007664completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to evaluate the feasibility of using reflectance confocal imaging to noninvasively detect and diagnose oral dysplasia and early carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Tumors | Oral Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Reflectance Confocal Imaging | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with oral lesions
- interventionNames
- Procedure: Reflectance Confocal Imaging
Primary outcomes (1)
- measure
- To study if using reflectance confocal imaging can detect and diagnose abnormal growths in the mouth and early cancer.
- timeFrame
- 6 Years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with oral lesions who give informed consent to participate in the study. * Any person with an oral lesion, particularly those suspicious for dysplasia or carcinoma. Exclusion Criteria: * Lack of any oral mucosal lesions * Oral lesions not physically accessible for probe placement or biopsy * Unwillingness to tolerate probe placement, dilute acetic acid rinse or biopsy * Unwillingness to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.